["Pregnancy \u2022 Paradoxical improvement in intrauterine growth, and a significant reduction of a combined outcome encompassing early preterm delivery (<28 gestational weeks) and birth weight < 10 percentile per gestational age \u2022 KAA supplementation is usually increased from 1 tablet every 10 kg in the first 20 weeks to 1 tablet every 5\u20138 kg in the second half of the pregnancy. Attini R.BMC Nephrol. 2016, 17, 132.","Short Life Expectancy \u2022 Life expectancy of less than 3 months is considered a relative contraindication to the start of a classic nutritional approach, mainly based upon protein restriction, in patients with CKD stage 3\u20134, since death is expected before CKD progression, Cupisti A. J Clin Med . 2020 Nov 12;9(11)-3644.","CKD patient not on dialysis (eGFR < 60 ml\/min\/1.73m2) Progressive disease Yes No \u2022 Poor attitude Metabolic complications Protein restriction \u2022 Psychiatric disorders No \u2022 Socioeconomic problems Continue current diet or \u2022 Poorly control DM recommend healthy diet \u2022 Chronic steroid treatment \u2022 Weight loss 0.2 g.\/Kg BW\/day \u2022 Short-life expectancy \u2022 Protein-energy wasting \u2022 Poor adherence Regular nutritional parameter follow up Correct or remove Yes any reversible No LPD or condition VLPD with KAA efficacy and safety Stop protein restriction","Thank You"]
Search
